Evidence map›Paper›PMID 41460290›Full record

ArticleWorld journal of urology2025

Adverse in-hospital outcomes after radical or partial nephrectomy in cardiac transplant patients.

Federico Polverino, Calogero Catanzaro, Michele Nicolazzini, Michele Petix, Leonardo Quarta, Maximilian Filzmayer, Nick Lee, Jordan A Goyal, Simone Morra, Claudia Collà Ruvolo and 11 more

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Federico PolverinoCancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada. fedepolve97@gmail.com.ORCID http://orcid.org/0009-0007-6218-3761
Calogero CatanzaroCancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.
Michele NicolazziniCancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.
Michele PetixCancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.
Leonardo QuartaCancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.
Maximilian FilzmayerCancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.
Nick LeeCancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.
Jordan A GoyalCancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.
Simone MorraCancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.
Claudia Collà RuvoloCancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.
Massimiliano CretaDepartment of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy.
Gianluigi CalifanoDepartment of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy.
Alberto BrigantiVita-Salute San Raffaele University, Milan, Italy.
Felix K H ChunDepartment of Urology, Goethe University Frankfurt, University Hospital, Frankfurt Am Main, Germany.
Carlotta PalumboDivision of Urology, Department of Translational Medicine, University of Eastern Piedmont, Maggiore Della Carità Hospital, Novara, Italy.
Riccardo SchiavinaDivision of Urology, IRCCS Azienda Ospedaliero-universitaria di Bologna, Bologna, Italy.
Gennaro MusiDepartment of Urology, IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, Milan, Italy.
Shahrokh F ShariatComprehensive Cancer Center, Department of Urology, Medical University of Vienna, Vienna, Austria.
Fred SaadCancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.
Nicola LongoDepartment of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy.
Pierre I KarakiewiczCancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCardiac transplant (CT) recipients represent a unique surgical population. However, it is unknown whether previous CT affects adverse in-hospital outcomes after partial nephrectomy (PN) or radical nephrectomy (RN).

methodsUsing the National Inpatient Sample (2000–2019), we analyzed kidney cancer patients undergoing PN or RN. Descriptive analyses, 1:10 propensity score matching (PSM), and multivariable logistic and Poisson regression models were applied, stratifying patients according to previous CT status.

resultsOverall, 39,373 patients underwent PN and 95,016 underwent RN; among them, 26 (0.1%) PN patients and 41 (0.1%) RN patients had a history of CT. CT status was not associated with significantly higher or lower rates of adverse in-hospital outcomes after either PN or RN. Specifically, among PN patients, CT was linked to higher rates of overall complications (+ 10.0%) and blood transfusions (+ 6.2%), but lower rates of cardiac (− 2.3%) and genitourinary complications (− 6.9%). Among RN patients, CT was associated with higher in-hospital mortality (+ 1.9%) but lower pulmonary complications (− 8.1%). After multivariable adjustment, CT status was not independently associated with any adverse in-hospital outcome for either PN or RN.

conclusionAdverse in-hospital outcomes were similar between CT and non-CT patients undergoing PN or RN, with only small absolute differences. These findings suggest that carefully selected and optimized CT patients can safely undergo PN or RN, making both procedures feasible options in this population.

Indexed as

Heart TransplantationKidney NeoplasmsNephrectomyPostoperative ComplicationsAgedFemaleHospital MortalityHumansMaleMiddle AgedRetrospective StudiesTreatment OutcomeCardiac transplantComplicationsKidney cancerNISPartial nephrectomyRadical nephrectomy

Identifiers

PMID41460290

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.